Global Ambrisentantable Market Research Report 2023

Ambrisentantable Market

Ambrisentan is an orally active selective type A endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension. It is approved in Europe, Canada and the United States for use as a single agent to improve exercise ability and delay clinical worsening. In addition, it is approved in the United States for use in combination with tadalafil to reduce the risks of disease progression, hospitalization and to improve exercise ability. Studies establishing the efficacy of Ambrisentan included patients with both idiopathic or heritable pulmonary arterial hypertension and those with pulmonary arterial hypertension associated with connective tissue diseases. Patients studied displayed symptoms and etiologies predominantly of WHO Functional Class II-III. As an endothelin receptor antagonist, Ambrisentan prevents endogenous endothelin peptide from constricting the muscles in blood vessels, allowing them to relax and permit a reduction in blood pressure.

The global Ambrisentantable market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Ambrisentantable is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Ambrisentantable is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Ambrisentantable include GSK, Actavis (TEVA ), Gilead Sciences, Mylan Pharmaceuticals, Sigmapharm Laboratories, Noorik BioPharma, Cipla, Cadila Healthcare and Sun Pharmaceutical Industries, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ambrisentantable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ambrisentantable.

The Ambrisentantable market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Ambrisentantable market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ambrisentantable manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Ambrisentantable Market Report

Core Chapters

1.1 Product Overview and Scope of Ambrisentantable

1.2 Ambrisentantable Segment by Type

1.2.1 Global Ambrisentantable Market Value Comparison by Type (2023-2029)

1.2.2 5 mg Tablet

1.2.3 10 mg Tablet

1.3 Ambrisentantable Segment by Application

1.3.1 Global Ambrisentantable Market Value by Application: (2023-2029)

1.3.2 Cirrhosis Of The Liver

1.3.3 High Blood Pressure

1.3.4 Hepatorenal Syndrome

1.3.5 Graft Function Is Delayed

1.3.6 Pulmonary Hypertension

1.3.7 Heart Failure

1.3.8 Chronic Renal Failure

1.3.9 Idiopathic Pulmonary Fibrosis

1.3.10 Other

1.4 Global Ambrisentantable Market Size Estimates and Forecasts

1.4.1 Global Ambrisentantable Revenue 2018-2029

1.4.2 Global Ambrisentantable Sales 2018-2029

1.4.3 Global Ambrisentantable Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Ambrisentantable Sales Market Share by Manufacturers (2018-2023)

2.2 Global Ambrisentantable Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Ambrisentantable Average Price by Manufacturers (2018-2023)

2.4 Global Ambrisentantable Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Ambrisentantable, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ambrisentantable, Product Type & Application

2.7 Ambrisentantable Market Competitive Situation and Trends

2.7.1 Ambrisentantable Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Ambrisentantable Players Market Share by Revenue

2.7.3 Global Ambrisentantable Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Ambrisentantable Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Ambrisentantable Global Ambrisentantable Sales by Region: 2018-2029

3.2.1 Global Ambrisentantable Sales by Region: 2018-2023

3.2.2 Global Ambrisentantable Sales by Region: 2024-2029

3.3 Global Ambrisentantable Global Ambrisentantable Revenue by Region: 2018-2029

3.3.1 Global Ambrisentantable Revenue by Region: 2018-2023

3.3.2 Global Ambrisentantable Revenue by Region: 2024-2029

3.4 North America Ambrisentantable Market Facts & Figures by Country

3.4.1 North America Ambrisentantable Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Ambrisentantable Sales by Country (2018-2029)

3.4.3 North America Ambrisentantable Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Ambrisentantable Market Facts & Figures by Country

3.5.1 Europe Ambrisentantable Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Ambrisentantable Sales by Country (2018-2029)

3.5.3 Europe Ambrisentantable Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ambrisentantable Market Facts & Figures by Country

3.6.1 Asia Pacific Ambrisentantable Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Ambrisentantable Sales by Country (2018-2029)

3.6.3 Asia Pacific Ambrisentantable Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Ambrisentantable Market Facts & Figures by Country

3.7.1 Latin America Ambrisentantable Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Ambrisentantable Sales by Country (2018-2029)

3.7.3 Latin America Ambrisentantable Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Ambrisentantable Market Facts & Figures by Country

3.8.1 Middle East and Africa Ambrisentantable Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Ambrisentantable Sales by Country (2018-2029)

3.8.3 Middle East and Africa Ambrisentantable Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Ambrisentantable Sales by Type (2018-2029)

4.1.1 Global Ambrisentantable Sales by Type (2018-2023)

4.1.2 Global Ambrisentantable Sales by Type (2024-2029)

4.1.3 Global Ambrisentantable Sales Market Share by Type (2018-2029)

4.2 Global Ambrisentantable Revenue by Type (2018-2029)

4.2.1 Global Ambrisentantable Revenue by Type (2018-2023)

4.2.2 Global Ambrisentantable Revenue by Type (2024-2029)

4.2.3 Global Ambrisentantable Revenue Market Share by Type (2018-2029)

4.3 Global Ambrisentantable Price by Type (2018-2029)

5.1 Global Ambrisentantable Sales by Application (2018-2029)

5.1.1 Global Ambrisentantable Sales by Application (2018-2023)

5.1.2 Global Ambrisentantable Sales by Application (2024-2029)

5.1.3 Global Ambrisentantable Sales Market Share by Application (2018-2029)

5.2 Global Ambrisentantable Revenue by Application (2018-2029)

5.2.1 Global Ambrisentantable Revenue by Application (2018-2023)

5.2.2 Global Ambrisentantable Revenue by Application (2024-2029)

5.2.3 Global Ambrisentantable Revenue Market Share by Application (2018-2029)

5.3 Global Ambrisentantable Price by Application (2018-2029)

6.1 GSK

6.1.1 GSK Corporation Information

6.1.2 GSK Description and Business Overview

6.1.3 GSK Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.1.4 GSK Ambrisentantable Product Portfolio

6.1.5 GSK Recent Developments/Updates

6.2 Actavis (TEVA )

6.2.1 Actavis (TEVA ) Corporation Information

6.2.2 Actavis (TEVA ) Description and Business Overview

6.2.3 Actavis (TEVA ) Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Actavis (TEVA ) Ambrisentantable Product Portfolio

6.2.5 Actavis (TEVA ) Recent Developments/Updates

6.3 Gilead Sciences

6.3.1 Gilead Sciences Corporation Information

6.3.2 Gilead Sciences Description and Business Overview

6.3.3 Gilead Sciences Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Gilead Sciences Ambrisentantable Product Portfolio

6.3.5 Gilead Sciences Recent Developments/Updates

6.4 Mylan Pharmaceuticals

6.4.1 Mylan Pharmaceuticals Corporation Information

6.4.2 Mylan Pharmaceuticals Description and Business Overview

6.4.3 Mylan Pharmaceuticals Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Mylan Pharmaceuticals Ambrisentantable Product Portfolio

6.4.5 Mylan Pharmaceuticals Recent Developments/Updates

6.5 Sigmapharm Laboratories

6.5.1 Sigmapharm Laboratories Corporation Information

6.5.2 Sigmapharm Laboratories Description and Business Overview

6.5.3 Sigmapharm Laboratories Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Sigmapharm Laboratories Ambrisentantable Product Portfolio

6.5.5 Sigmapharm Laboratories Recent Developments/Updates

6.6 Noorik BioPharma

6.6.1 Noorik BioPharma Corporation Information

6.6.2 Noorik BioPharma Description and Business Overview

6.6.3 Noorik BioPharma Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Noorik BioPharma Ambrisentantable Product Portfolio

6.6.5 Noorik BioPharma Recent Developments/Updates

6.7 Cipla

6.6.1 Cipla Corporation Information

6.6.2 Cipla Description and Business Overview

6.6.3 Cipla Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Cipla Ambrisentantable Product Portfolio

6.7.5 Cipla Recent Developments/Updates

6.8 Cadila Healthcare

6.8.1 Cadila Healthcare Corporation Information

6.8.2 Cadila Healthcare Description and Business Overview

6.8.3 Cadila Healthcare Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Cadila Healthcare Ambrisentantable Product Portfolio

6.8.5 Cadila Healthcare Recent Developments/Updates

6.9 Sun Pharmaceutical Industries

6.9.1 Sun Pharmaceutical Industries Corporation Information

6.9.2 Sun Pharmaceutical Industries Description and Business Overview

6.9.3 Sun Pharmaceutical Industries Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Sun Pharmaceutical Industries Ambrisentantable Product Portfolio

6.9.5 Sun Pharmaceutical Industries Recent Developments/Updates

6.10 Hansoh Pharma

6.10.1 Hansoh Pharma Corporation Information

6.10.2 Hansoh Pharma Description and Business Overview

6.10.3 Hansoh Pharma Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Hansoh Pharma Ambrisentantable Product Portfolio

6.10.5 Hansoh Pharma Recent Developments/Updates

6.11 CTTQ

6.11.1 CTTQ Corporation Information

6.11.2 CTTQ Ambrisentantable Description and Business Overview

6.11.3 CTTQ Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.11.4 CTTQ Ambrisentantable Product Portfolio

6.11.5 CTTQ Recent Developments/Updates

6.12 Zhejiang Haosen Pharmaceutical

6.12.1 Zhejiang Haosen Pharmaceutical Corporation Information

6.12.2 Zhejiang Haosen Pharmaceutical Ambrisentantable Description and Business Overview

6.12.3 Zhejiang Haosen Pharmaceutical Ambrisentantable Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Zhejiang Haosen Pharmaceutical Ambrisentantable Product Portfolio

6.12.5 Zhejiang Haosen Pharmaceutical Recent Developments/Updates

7.1 Ambrisentantable Industry Chain Analysis

7.2 Ambrisentantable Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ambrisentantable Production Mode & Process

7.4 Ambrisentantable Sales and Marketing

7.4.1 Ambrisentantable Sales Channels

7.4.2 Ambrisentantable Distributors

7.5 Ambrisentantable Customers

8.1 Ambrisentantable Industry Trends

8.2 Ambrisentantable Market Drivers

8.3 Ambrisentantable Market Challenges

8.4 Ambrisentantable Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Ambrisentantable Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Ambrisentantable Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Ambrisentantable Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Ambrisentantable Sales (M Pcs) of Key Manufacturers (2018-2023)

    Table 5. Global Ambrisentantable Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Ambrisentantable Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Ambrisentantable Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Ambrisentantable Average Price (US$/Pcs) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Ambrisentantable, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Ambrisentantable, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Ambrisentantable, Product Type & Application

    Table 12. Global Key Manufacturers of Ambrisentantable, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Ambrisentantable by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ambrisentantable as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Ambrisentantable Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Ambrisentantable Sales by Region (2018-2023) & (M Pcs)

    Table 18. Global Ambrisentantable Sales Market Share by Region (2018-2023)

    Table 19. Global Ambrisentantable Sales by Region (2024-2029) & (M Pcs)

    Table 20. Global Ambrisentantable Sales Market Share by Region (2024-2029)

    Table 21. Global Ambrisentantable Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Ambrisentantable Revenue Market Share by Region (2018-2023)

    Table 23. Global Ambrisentantable Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Ambrisentantable Revenue Market Share by Region (2024-2029)

    Table 25. North America Ambrisentantable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Ambrisentantable Sales by Country (2018-2023) & (M Pcs)

    Table 27. North America Ambrisentantable Sales by Country (2024-2029) & (M Pcs)

    Table 28. North America Ambrisentantable Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Ambrisentantable Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Ambrisentantable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Ambrisentantable Sales by Country (2018-2023) & (M Pcs)

    Table 32. Europe Ambrisentantable Sales by Country (2024-2029) & (M Pcs)

    Table 33. Europe Ambrisentantable Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Ambrisentantable Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Ambrisentantable Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Ambrisentantable Sales by Region (2018-2023) & (M Pcs)

    Table 37. Asia Pacific Ambrisentantable Sales by Region (2024-2029) & (M Pcs)

    Table 38. Asia Pacific Ambrisentantable Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Ambrisentantable Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Ambrisentantable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Ambrisentantable Sales by Country (2018-2023) & (M Pcs)

    Table 42. Latin America Ambrisentantable Sales by Country (2024-2029) & (M Pcs)

    Table 43. Latin America Ambrisentantable Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Ambrisentantable Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Ambrisentantable Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Ambrisentantable Sales by Country (2018-2023) & (M Pcs)

    Table 47. Middle East & Africa Ambrisentantable Sales by Country (2024-2029) & (M Pcs)

    Table 48. Middle East & Africa Ambrisentantable Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Ambrisentantable Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Ambrisentantable Sales (M Pcs) by Type (2018-2023)

    Table 51. Global Ambrisentantable Sales (M Pcs) by Type (2024-2029)

    Table 52. Global Ambrisentantable Sales Market Share by Type (2018-2023)

    Table 53. Global Ambrisentantable Sales Market Share by Type (2024-2029)

    Table 54. Global Ambrisentantable Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Ambrisentantable Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Ambrisentantable Revenue Market Share by Type (2018-2023)

    Table 57. Global Ambrisentantable Revenue Market Share by Type (2024-2029)

    Table 58. Global Ambrisentantable Price (US$/Pcs) by Type (2018-2023)

    Table 59. Global Ambrisentantable Price (US$/Pcs) by Type (2024-2029)

    Table 60. Global Ambrisentantable Sales (M Pcs) by Application (2018-2023)

    Table 61. Global Ambrisentantable Sales (M Pcs) by Application (2024-2029)

    Table 62. Global Ambrisentantable Sales Market Share by Application (2018-2023)

    Table 63. Global Ambrisentantable Sales Market Share by Application (2024-2029)

    Table 64. Global Ambrisentantable Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Ambrisentantable Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Ambrisentantable Revenue Market Share by Application (2018-2023)

    Table 67. Global Ambrisentantable Revenue Market Share by Application (2024-2029)

    Table 68. Global Ambrisentantable Price (US$/Pcs) by Application (2018-2023)

    Table 69. Global Ambrisentantable Price (US$/Pcs) by Application (2024-2029)

    Table 70. GSK Corporation Information

    Table 71. GSK Description and Business Overview

    Table 72. GSK Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 73. GSK Ambrisentantable Product

    Table 74. GSK Recent Developments/Updates

    Table 75. Actavis (TEVA ) Corporation Information

    Table 76. Actavis (TEVA ) Description and Business Overview

    Table 77. Actavis (TEVA ) Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 78. Actavis (TEVA ) Ambrisentantable Product

    Table 79. Actavis (TEVA ) Recent Developments/Updates

    Table 80. Gilead Sciences Corporation Information

    Table 81. Gilead Sciences Description and Business Overview

    Table 82. Gilead Sciences Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 83. Gilead Sciences Ambrisentantable Product

    Table 84. Gilead Sciences Recent Developments/Updates

    Table 85. Mylan Pharmaceuticals Corporation Information

    Table 86. Mylan Pharmaceuticals Description and Business Overview

    Table 87. Mylan Pharmaceuticals Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 88. Mylan Pharmaceuticals Ambrisentantable Product

    Table 89. Mylan Pharmaceuticals Recent Developments/Updates

    Table 90. Sigmapharm Laboratories Corporation Information

    Table 91. Sigmapharm Laboratories Description and Business Overview

    Table 92. Sigmapharm Laboratories Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 93. Sigmapharm Laboratories Ambrisentantable Product

    Table 94. Sigmapharm Laboratories Recent Developments/Updates

    Table 95. Noorik BioPharma Corporation Information

    Table 96. Noorik BioPharma Description and Business Overview

    Table 97. Noorik BioPharma Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 98. Noorik BioPharma Ambrisentantable Product

    Table 99. Noorik BioPharma Recent Developments/Updates

    Table 100. Cipla Corporation Information

    Table 101. Cipla Description and Business Overview

    Table 102. Cipla Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 103. Cipla Ambrisentantable Product

    Table 104. Cipla Recent Developments/Updates

    Table 105. Cadila Healthcare Corporation Information

    Table 106. Cadila Healthcare Description and Business Overview

    Table 107. Cadila Healthcare Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 108. Cadila Healthcare Ambrisentantable Product

    Table 109. Cadila Healthcare Recent Developments/Updates

    Table 110. Sun Pharmaceutical Industries Corporation Information

    Table 111. Sun Pharmaceutical Industries Description and Business Overview

    Table 112. Sun Pharmaceutical Industries Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 113. Sun Pharmaceutical Industries Ambrisentantable Product

    Table 114. Sun Pharmaceutical Industries Recent Developments/Updates

    Table 115. Hansoh Pharma Corporation Information

    Table 116. Hansoh Pharma Description and Business Overview

    Table 117. Hansoh Pharma Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 118. Hansoh Pharma Ambrisentantable Product

    Table 119. Hansoh Pharma Recent Developments/Updates

    Table 120. CTTQ Corporation Information

    Table 121. CTTQ Description and Business Overview

    Table 122. CTTQ Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 123. CTTQ Ambrisentantable Product

    Table 124. CTTQ Recent Developments/Updates

    Table 125. Zhejiang Haosen Pharmaceutical Corporation Information

    Table 126. Zhejiang Haosen Pharmaceutical Description and Business Overview

    Table 127. Zhejiang Haosen Pharmaceutical Ambrisentantable Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 128. Zhejiang Haosen Pharmaceutical Ambrisentantable Product

    Table 129. Zhejiang Haosen Pharmaceutical Recent Developments/Updates

    Table 130. Key Raw Materials Lists

    Table 131. Raw Materials Key Suppliers Lists

    Table 132. Ambrisentantable Distributors List

    Table 133. Ambrisentantable Customers List

    Table 134. Ambrisentantable Market Trends

    Table 135. Ambrisentantable Market Drivers

    Table 136. Ambrisentantable Market Challenges

    Table 137. Ambrisentantable Market Restraints

    Table 138. Research Programs/Design for This Report

    Table 139. Key Data Information from Secondary Sources

    Table 140. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Ambrisentantable

    Figure 2. Global Ambrisentantable Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Ambrisentantable Market Share by Type in 2022 & 2029

    Figure 4. 5 mg Tablet Product Picture

    Figure 5. 10 mg Tablet Product Picture

    Figure 6. Global Ambrisentantable Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Ambrisentantable Market Share by Application in 2022 & 2029

    Figure 8. Cirrhosis Of The Liver

    Figure 9. High Blood Pressure

    Figure 10. Hepatorenal Syndrome

    Figure 11. Graft Function Is Delayed

    Figure 12. Pulmonary Hypertension

    Figure 13. Heart Failure

    Figure 14. Chronic Renal Failure

    Figure 15. Idiopathic Pulmonary Fibrosis

    Figure 16. Other

    Figure 17. Global Ambrisentantable Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Ambrisentantable Market Size (2018-2029) & (US$ Million)

    Figure 19. Global Ambrisentantable Sales (2018-2029) & (M Pcs)

    Figure 20. Global Ambrisentantable Average Price (US$/Pcs) & (2018-2029)

    Figure 21. Ambrisentantable Report Years Considered

    Figure 22. Ambrisentantable Sales Share by Manufacturers in 2022

    Figure 23. Global Ambrisentantable Revenue Share by Manufacturers in 2022

    Figure 24. The Global 5 and 10 Largest Ambrisentantable Players: Market Share by Revenue in 2022

    Figure 25. Ambrisentantable Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 26. Global Ambrisentantable Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 27. North America Ambrisentantable Sales Market Share by Country (2018-2029)

    Figure 28. North America Ambrisentantable Revenue Market Share by Country (2018-2029)

    Figure 29. U.S. Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Canada Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Europe Ambrisentantable Sales Market Share by Country (2018-2029)

    Figure 32. Europe Ambrisentantable Revenue Market Share by Country (2018-2029)

    Figure 33. Germany Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. France Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. U.K. Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Italy Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Russia Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Asia Pacific Ambrisentantable Sales Market Share by Region (2018-2029)

    Figure 39. Asia Pacific Ambrisentantable Revenue Market Share by Region (2018-2029)

    Figure 40. China Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Japan Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. South Korea Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. India Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Australia Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Taiwan Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Indonesia Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Thailand Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Malaysia Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Philippines Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Latin America Ambrisentantable Sales Market Share by Country (2018-2029)

    Figure 51. Latin America Ambrisentantable Revenue Market Share by Country (2018-2029)

    Figure 52. Mexico Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Brazil Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Argentina Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Middle East & Africa Ambrisentantable Sales Market Share by Country (2018-2029)

    Figure 56. Middle East & Africa Ambrisentantable Revenue Market Share by Country (2018-2029)

    Figure 57. Turkey Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 58. Saudi Arabia Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 59. UAE Ambrisentantable Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 60. Global Sales Market Share of Ambrisentantable by Type (2018-2029)

    Figure 61. Global Revenue Market Share of Ambrisentantable by Type (2018-2029)

    Figure 62. Global Ambrisentantable Price (US$/Pcs) by Type (2018-2029)

    Figure 63. Global Sales Market Share of Ambrisentantable by Application (2018-2029)

    Figure 64. Global Revenue Market Share of Ambrisentantable by Application (2018-2029)

    Figure 65. Global Ambrisentantable Price (US$/Pcs) by Application (2018-2029)

    Figure 66. Ambrisentantable Value Chain

    Figure 67. Ambrisentantable Production Process

    Figure 68. Channels of Distribution (Direct Vs Distribution)

    Figure 69. Distributors Profiles

    Figure 70. Bottom-up and Top-down Approaches for This Report

    Figure 71. Data Triangulation

    Figure 72. Key Executives Interviewed